.jpg)
‘A safe place to fail’: ARPA-H chief on building a culture of risk-taking in science
Renee Wegrzyn has been assembling teams her whole career — in academia, industry, and government….
Category: Politics
STAT+: Federal Medicaid officials cajole states to auto-enroll beneficiaries as huge coverage losses loom
WASHINGTON — Federal Medicaid officials are working unusually closely with states to avoid enrollment glitches…
STAT+: Here’s why there aren’t many cheap, generic versions of pricey inhalers
U.S. regulators approved dozens of inhalers to treat asthma and chronic obstructive pulmonary disease over…
STAT+: Califf criticizes insurers for doing too little on drug research
WASHINGTON — FDA Commissioner Robert Califf wants private insurers to chip in on doing post-approval…
STAT+: The big-money Medicare policy that has hospitals worried this Congress
WASHINGTON — There are few things that get lawmakers in Washington salivating more than a wonky…
.jpg)
STAT+: Medicare explains how it will choose drugs for negotiation
WASHINGTON — Medicare laid out Thursday in the greatest detail yet how it will choose…
STAT+: Would the federal government defer to states to regulate PBMs?
WASHINGTON — After years of struggling to regulate the drug middlemen that create pharmacy networks,…
STAT+: White House chooses a location for ARPA-H — sort of
WASHINGTON — Officials at the Advanced Research Projects Agency for Health are moving ahead with…
STAT+: Biden administration to fine manufacturers of 27 medicines for price hikes
WASHINGTON — The Biden administration will fine drugmakers who hiked prices faster than the rate…
STAT+: PhRMA chief dings health insurers over drug prices at their own conference
WASHINGTON — The head of the brand drug lobby used an in-person health insurance industry…
‘Leave the chocolate milk out of this’: School cooks, parents, kids push back on USDA effort to make lunches healthier
WASHINGTON — The feds are coming for your kids’ chocolate milk. At least, so says…
STAT+: Medicare will take R&D costs, effectiveness into account when it negotiates drug prices. But studies show that doesn’t affect prices
By law, Medicare will have to take a medication’s efficacy and its research and development…
STAT+: Biden makes big demands for cancer research and new ARPA-H agency
President Biden is banking on longtime bipartisan interest in eliminating cancer deaths to secure some…
Biden administration requests $20 billion cash infusion to bolster public health
WASHINGTON — The Biden administration is calling for a big boost for public health funding…
STAT+: Biden makes drug pricing a central part of his deficit reduction plans
WASHINGTON – President Biden made lowering drug prices a key part of his budget with…
STAT+: Insulin for $20 a vial? Sanders pushes bill for price caps on the diabetes treatment
Now that Eli Lilly is cutting prices on some of its insulin products, U.S. Sen….
With a $11 billion price tag, the White House pitches a plan to end hepatitis C
WASHINGTON – The Biden administration is calling on Congress to fund a more than $11…
STAT+: An unlikely new 340B alliance emerges between PhRMA and community health centers
WASHINGTON — An unusual new alliance of the brand-drug lobby PhRMA and community health centers…
Pfizer CEO Albert Bourla maxed out campaign contributions to Dr. Oz ahead of midterm elections
WASHINGTON — Pfizer CEO Albert Bourla made the maximum possible campaign contribution to Mehmet Oz…
‘Truth is losing the battle’: FDA commissioner on grappling with a wave of health misinformation
The Food and Drug Administration is considering whether it needs to revamp guidance on how…
STAT+: Medicare chief on the new drug price negotiation program’s operations, hiring, and timelines
WASHINGTON — Medicare officials are still hammering out the technical specifics of how the massive…
Revamped Covid panel argues for research limits, even bans
WASHINGTON — Pathogen-altering research is back under fire here, as Republican lawmakers argue it should…
HHS secretary signals support for new restriction on addiction treatment
WASHINGTON — A federal proposal to impose new restrictions on a key addiction-treatment medication has…
Becerra: Judge set to rule on abortion pill is ‘beginning to read the law’
WASHINGTON — Health secretary Xavier Becerra on Tuesday warned of dramatic consequences if a federal…
Science adviser Collins hints at a big White House ask to eliminate hepatitis C
WASHINGTON — The Biden administration will request “significant investments” to help eliminate hepatitis C in…
Biden proposes expanding Medicare drug negotiation program
WASHINGTON — The Biden administration will propose expanding Democrats’ new drug pricing law by allowing…
STAT+: Teva quits brand lobby PhRMA, in line to lead generic lobby AAM
WASHINGTON — Teva Pharmaceuticals has quit the Pharmaceutical Research and Manufacturers of America, STAT has…
STAT+: From industry ‘greed’ to workforce shortages, Sanders and Cassidy lay out health committee agenda
The Senate finally made long-expected committee assignments official on Thursday, kickstarting a new session for…
STAT+: New York’s hospitals are poised for political power this Congress
WASHINGTON — The new Democratic leadership team in Congress is pretty much the New York…
STAT+: Medicare may test policy of paying less for accelerated approval drugs
A Medicare official hinted Tuesday that Medicare might test a policy of paying less for…
STAT+: FDA may not always require post-approval trials to be enrolled before accelerated approvals
WASHINGTON — A Food and Drug Administration official on Monday gave more clues for how…
President Biden to end Covid-19 emergencies on May 11
WASHINGTON — President Joe Biden informed Congress on Monday that he will end the twin…
It’s easy to buy flavored vapes in California, even in cities with longtime bans
LOS ANGELES – California cities are supposed to be cracking down on sales of flavored…
HHS’ Becerra on enrolling in Medicare, annual Covid vaccines, and seniors’ mental health
WASHINGTON — The hottest birthday spot in town: A Hispanic senior center in northwest D.C….
After nearly 4 years of deliberation, FDA punts on how to regulate CBD
WASHINGTON — The FDA is giving up on trying to figure out a way to…
STAT+: The unexpected alliance lobbying for Medicare to pay for new obesity drugs
WASHINGTON — It’s not every day that the pharmaceutical industry, the NAACP, a cancer center, and…
New lawsuits target state restrictions on abortion pills
WASHINGTON — Supporters of abortion rights filed separate lawsuits Wednesday challenging two states’ abortion pill…
STAT+: The 4 biggest questions about the FDA’s forthcoming changes to accelerated approvals
WASHINGTON — Congress just boosted the FDA’s authority over the post-market clinical trials that are…
STAT+: Liquid-biopsy firm Grail is spending more than ever lobbying Congress
Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the…
STAT+: Health groups like AHA, PhRMA channeled millions into end-of-year legislative debates
WASHINGTON — Health care groups and their lobbyists spent big in the last few months…
STAT+: PhRMA terminates lobbying contract with White House official’s brother
WASHINGTON — The pharmaceutical industry lobbying group PhRMA has severed its contract with a lobbyist who…
STAT+: Pallone pushes NIH and FDA to disclose steps being taken to ensure clinical trial results are reported
A Democratic lawmaker is demanding to know what steps the U.S. Food and Drug Administration…
‘Hot mess’: Abortion pills at pharmacies could face legal quagmires, especially in restrictive states
WASHINGTON — Federal regulators’ green light for pharmacists to dispense abortion pills is crashing into…
HHS needs better oversight of research that alters pathogens, government watchdog says
WASHINGTON — The health department’s oversight of research that could enhance dangerous pathogens has vague…
STAT+: Hip and knee replacements go better when performed by high-volume surgeons, new study finds
A new study underscores the importance of the adage “practice makes perfect,” especially when it…
Opinion: Biopharma leaders helped save democracy. Now what?
The rule of law must be upheld for free societies and free markets to flourish,…
STAT+: Congressional Medicare advisers warn of higher drug prices, despite new price negotiation
WASHINGTON — Despite the pharmaceutical industry’s loud complaints to the contrary, the new law directing…
Biden Covid adviser David Kessler to exit as pandemic response winds down
WASHINGTON — David Kessler, the D.C. veteran who guided government dispatches of millions of Covid-19…
STAT+: Oscar Health’s CEO on post-hype health insurance and finally turning a profit
Oscar Health has excelled at one thing in particular since its inception a decade ago:…
STAT+: With the FTC’s more expansive approach to antitrust, PBMs are in the crosshairs
WASHINGTON — The Democrats leading the Federal Trade Commission are hoping to expand the agency’s…